Citations refer to the original publication, not to a Scieee localized version.
Ferrer, I., Quintanal Villalonga, Á. D., Molina Pinelo, S., García Heredia, J. M., Pérez, M., & Carnero Moya, A. (2018). MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma. BMC. https://doi.org/10.1186/s13046-018-0871-7
Ferrer, Irene, et al. MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma. BMC, 2018. https://doi.org/10.1186/s13046-018-0871-7.
Ferrer, Irene, Álvaro Diego Quintanal Villalonga, Sonia Molina Pinelo, José Manuel García Heredia, Marco Pérez, and Amancio Carnero Moya. MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma. BMC, 2018. https://doi.org/10.1186/s13046-018-0871-7.
Ferrer, I. et al. (2018) MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma. BMC. Available at: https://doi.org/10.1186/s13046-018-0871-7.
I. Ferrer, Á. D. Quintanal Villalonga, S. Molina Pinelo, J. M. García Heredia, M. Pérez, and A. Carnero Moya, “MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma,” BMC, 2018, doi: 10.1186/s13046-018-0871-7.
@misc{ferrer2018map17,
author = {Ferrer, Irene and Quintanal Villalonga, Álvaro Diego and Molina Pinelo, Sonia and García Heredia, José Manuel and Pérez, Marco and Carnero Moya, Amancio},
title = {MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma},
year = {2018},
publisher = {BMC},
doi = {10.1186/s13046-018-0871-7},
url = {https://doi.org/10.1186/s13046-018-0871-7}
}
The source metadata has no journal, volume or pages. Add them from the original publication if your citation needs them.
